Identifying participants’ preferences for modifiable chemotherapy-induced peripheral neuropathy prevention clinical trial factors: an adaptive choice-based conjoint analysis

PURPOSE: There are no recommended treatments for chemotherapy-induced peripheral neuropathy (CIPN) prevention. Recruitment to CIPN prevention clinical trials is challenging because it is difficult to enroll patients between the time of cancer diagnosis and the initiation of neurotoxic chemotherapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Knoerl, Robert, Berry, Donna, Meyerhardt, Jeffrey A., Reyes, Kaitlen, Salehi, Elahe, Thornton, Katherine, Gewandter, Jennifer S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648439/
https://www.ncbi.nlm.nih.gov/pubmed/36355216
http://dx.doi.org/10.1007/s00520-022-07447-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648439/
https://www.ncbi.nlm.nih.gov/pubmed/36355216
http://dx.doi.org/10.1007/s00520-022-07447-y

Ejemplares similares